Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis
- 10 December 2013
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (4) , 1159-1165
Abstract
Background Most patients with malignant peritoneal mesothelioma (MPM) present with late-stage, unresectable disease that responds poorly to systemic chemotherapy while, at the same time, effective...Keywords
This publication has 33 references indexed in Scilit:
- A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesotheliomaMutation Research - Reviews in Mutation Research, 2012
- Second Generation Sequencing of the Mesothelioma Tumor GenomePLOS ONE, 2010
- Surgical Techniques in Visceral Resection and Peritonectomy ProceduresThe Cancer Journal, 2009
- Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapyJournal of Surgical Oncology, 2008
- Phase II Trial of Pemetrexed and Gemcitabine in Chemotherapy-Naïve Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2008
- Advances in the systemic therapy of malignant pleural mesotheliomaNature Clinical Practice Oncology, 2008
- Radical surgery‐peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancerJournal of Surgical Oncology, 2006
- Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapyBritish Journal of Surgery, 2004
- Analysis of Factors Associated With Outcome in Patients With Malignant Peritoneal Mesothelioma Undergoing Surgical Debulking and Intraperitoneal ChemotherapyJournal of Clinical Oncology, 2003
- Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapyCancer Treatment Reviews, 2001